Wednesday, July 8, 2026

Patent intelligence · US

US 11752184

Bioactive concentrates and uses thereof

granted A61KA61K2236/00A61K36/185A61P
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 17
Applicant portfolio 3
Patent details — US 11752184
Jurisdiction
US
Status
granted
Grant date
Sep 12, 2023
Expiration
Sep 7, 2043
Applicant
PURPLE MUNDO, INC.
Claims
17
CPC classes
A61K, A61K2236/00, A61K36/185, A61P
View on Google Patents ↗

Quick answer

US 11752184 (Bioactive concentrates and uses thereof) is held by PURPLE MUNDO, INC.. Status: granted. Granted Sep 12, 2023. Expires Sep 7, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Applicant
PURPLE MUNDO, INC.
Grant date
Expiration
Claims
17
CPC classes
A61K, A61K2236/00, A61K36/185, A61P, A61P25/00

More from PURPLE MUNDO, INC.

Related pharmaceutical patents in our USPTO index.

  1. US 12378277

    SGLTS/DPP4 inhibitor and application thereof

    DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., LTD. · Expires Jul 31, 2045

    granted
  2. US 11484523

    Compositions for prevention and treatment of symptoms associated with alcohol consumption

    Purple Biosciences LLC · Expires Oct 27, 2042

    granted

Frequently asked questions

What is US patent 11752184?

US 11752184 (Bioactive concentrates and uses thereof) is held by PURPLE MUNDO, INC.. Status: granted. Granted Sep 12, 2023. Expires Sep 7, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 11752184?

PURPLE MUNDO, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3 pharmaceutical patents for this assignee.

When does US 11752184 expire?

Our index shows an expiration date of Sep 7, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.